All Hong Kong stocks quotes are at least 15 minutes delayed.
06185
CANSINOBIO
HKD
37.120-0.460
(-1.22%)
1D
High
37.900
Open
37.600
VWAP
37.46
Vol
229.60K
Mkt Cap
--
Low
37.120
Amount
8.60M
EV/EBITDA(TTM)
--
Total Shares
--
EV
11.11B
EV/OCF(TTM)
2.14K
P/S(TTM)
18.93
CanSino Biologics Inc is a China-based company primarily engaged in the research and development, production, and commercialization of human vaccine products. The Company’s products and product pipeline under research include multiple vaccine varieties such as meningitis, pneumonia, diphtheria, tetanus, and pertussis (DPT), coronavirus disease 2019 (COVID-19), Ebola virus disease, poliomyelitis, herpes zoster, tuberculosis and others. The Company is also engaged in the research and development of pharmaceutical production processes. The Company conducts its business in the domestic and overseas markets.
Show More
News
Money Flow
Over the past 66 trading days, overall net money flow is 43.57M, with retail investors contributing 3.58M and major investors adding 33.81M.
Net Buy $ Volume
Net Sell $ Volume
No data
Valuation Metrics
Forward PE
N/A
5Y Average PE
20.54
Current PE
47.12
Overvalued PE
282.44
Undervalued PE
-241.37
Forward EV/EBITDA
N/A
5Y Average EV/EBITDA
39.32
Current EV/EBITDA
36.95
Overvalued EV/EBITDA
96.19
Undervalued EV/EBITDA
-17.55
Forward PS
5Y Average PS
14.01
Current PS
8.84
Overvalued PS
26.39
Undervalued PS
1.62
Financials
Al Analysis
Annual
Quarterly
Trading Trends
Daily
Monthly
No data
Short Selling
People Also Watch